摩熵化学
数据开放平台 数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-cyclohexyl-2-[[2-[2-[(5-methyl-1,2-oxazol-3-yl)amino]-2-oxoethyl]sulfanylacetyl]-quinolin-3-ylamino]-2-thiophen-2-ylacetamide

中文名称
——
中文别名
——
英文名称
N-cyclohexyl-2-[[2-[2-[(5-methyl-1,2-oxazol-3-yl)amino]-2-oxoethyl]sulfanylacetyl]-quinolin-3-ylamino]-2-thiophen-2-ylacetamide
英文别名
——
N-cyclohexyl-2-[[2-[2-[(5-methyl-1,2-oxazol-3-yl)amino]-2-oxoethyl]sulfanylacetyl]-quinolin-3-ylamino]-2-thiophen-2-ylacetamide化学式
CAS
——
化学式
C29H31N5O4S2
mdl
——
分子量
577.7
InChiKey
BHCTXPZDPMLBKX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    40
  • 可旋转键数:
    10
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.34
  • 拓扑面积:
    171
  • 氢给体数:
    2
  • 氢受体数:
    8

文献信息

  • Compositions useful in treating brain-related diseases or disorders and methods using same
    申请人:DREXEL UNIVERSITY
    公开号:US10287290B2
    公开(公告)日:2019-05-14
    The present invention provides compounds useful for treating or preventing a brain-related disease or disorder. The present invention further provides a method of treating or preventing a brain-related disease or disorder in a patient, comprising administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of modulating the activity of a monoamine transporter.
    本发明提供了用于治疗或预防脑相关疾病或紊乱的化合物。本发明进一步提供了一种治疗或预防患者脑相关疾病或紊乱的方法,包括向患者施用包含至少一种本发明化合物的药物组合物。本发明进一步提供了一种调节单胺转运体活性的方法。
  • NOVEL COMPOSITIONS USEFUL IN TREATING BRAIN-RELATED DISEASES OR DISORDERS AND METHODS USING SAME
    申请人:DREXEL UNIVERSITY
    公开号:US20160074408A1
    公开(公告)日:2016-03-17
    The present invention provides compounds useful for treating or preventing a brain-related disease or disorder. The present invention further provides a method of treating or preventing a brain-related disease or disorder in a patient, the method comprising administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of modulating the activity of a monoamine transporter.
  • US9616065B2
    申请人:——
    公开号:US9616065B2
    公开(公告)日:2017-04-11
  • [EN] NOVEL COMPOSITIONS USEFUL IN TREATING BRAIN-RELATED DISEASES OR DISORDERS AND METHODS USING SAME<br/>[FR] NOUVELLES COMPOSITIONS UTILISÉES POUR LE TRAITEMENT DE MALADIES OU D'AFFECTIONS LIÉES AU CERVEAU, ET MÉTHODES UTILISANT CES COMPOSITIONS
    申请人:PHILADELPHIA HEALTH & EDUCATIO
    公开号:WO2014172453A2
    公开(公告)日:2014-10-23
    The present invention provides compounds useful for treating or preventing a brain-related disease or disorder. The present invention further provides a method of treating or preventing a brain-related disease or disorder in a patient, comprising administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of modulating the activity of a monoamine transporter.
查看更多